Testing by the National Medicines Institute (OMCL) showed an out-of-specification result for the release parameter at a defined time point and temperature, meaning the product does not meet quality requirements and concerns a critical parameter affecting the drug’s action. Potential effects: lack of therapeutic efficacy or its disturbance, possible clinical complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from the suspended batches. Patients should contact their physician to determine further treatment and any therapy change. Pharmacies and healthcare institutions should not disp...
The marketing of the medicinal product RISPERIDONE TEVA 37.5 mg for all batches was suspended throughout the country, and the decision was given immediate enforceability after a negative quality test ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related